Home » Authors » Nuala Moran

Articles by Nuala Moran

Ark Therapeutics' Gene Therapy Doubles Survival In Early Trial

April 11, 2001

Diversys Enters $10M Alliance, Secures $10M In Private Funding

April 11, 2001

Diversys Enters $10M Alliance, Secures $10M In Private Funding

April 11, 2001

Ark Therapeutics' Gene Therapy Doubles Survival In Early Trial

April 11, 2001

UK Parliament Seeks Moratorium On Insurers' Use Of Genetic Tests

April 11, 2001

Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms

April 4, 2001

Oxford Gene, Affymetrix Settle Microarray Patent Litigation

April 4, 2001

Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms

April 4, 2001

Oxford Gene, Affymetrix Settle Microarray Patent Litigation

April 4, 2001

Proteome Sciences Establishing Proteomics Facility, Collaboration

March 28, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 15, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
Biopharma tariffs becoming more than a threat
BioWorld
U.S. tariffs on biopharmaceuticals have advanced beyond administration talking points.As a precursor to tariffs, Commerce Secretary Howard Lutnick initiated an...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...